Page 151 - Read Online
P. 151

Page 302                   Balasubramaniam et al. J Transl Genet Genom 2020;4:285-306  I  http://dx.doi.org/10.20517/jtgg.2020.34

               27.  Chiong MS, Sim KG, Carpenter K, Rhead W, Ho G, et al. Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female
                   caused by maternal riboflavin deficiency. Mol Genet Metab 2007;92:109-14.
               28.  Ho G, Yonezawa A, Masuda S, Inui K, Sim KG, et al. Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria
                   Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172B. Hum Mutat 2011;32:E1976-84.
               29.  Mosegaard S, Bruun GH, Flybjerg KF, Bliksrud YT, Gregersen N, et al. An intronic variation in SLC52A1 causes exon skipping and
                   transient riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Mol Genet Metab 2017;122:182-8.
               30.  Schiff M, Veauville-Merllie A, Acquaviva-Bourdain C. SLC25A32 mutations and riboflavin-responsive exercise intolerance. N Engl J
                   Med 2016;374:795-7.
               31.  Hellebrekers DMEI, Sallevelt SCEH, Theunissen TEJ, Hendrickx ATM, Gottschalk RW, et al. Novel SLC25A32 mutation in a patient
                   with a severe neuromuscular phenotype. Eur J Hum Genet 2017;25:886-8.
               32.  Santoro V, Kovalenko I, Vriens K, Christen S, Bernthaler A, et al. SLC25A32 sustains cancer cell proliferation by regulating flavin
                   adenine nucleotide (FAD) metabolism. Oncotarget 2020;11:801-12.
               33.  Giancaspero TA, Colella M, Brizio C, Difonzo G, Fiorino GM, et al. Remaining challenges in cellular flavin cofactor homeostasis and
                   flavoprotein biogenesis. Front Chem 2015;22:30.
               34.  Olsen RKJ, Konarikova E, Giancaspero TA, Mosegaard S, Boczonadi V, et al. Riboflavin responsive and-non-responsive mutations in
                   FAD synthase cause multiple acyl-CoA dehydrogenase and combined respiratory-chain deficiency. Am J Hum Genet 2016;98:1130-45.
               35.  Torchetti EM, Brizio C, Colella M, Galluccio M, Giancaspero TA, et al. Mitochondrial localization of human FAD synthetase isoform 1.
                   Mitochondrion 2010;10:263-73.
               36.  Giancaspero TA, Busco G, Panebianco C, Carmone C, Miccolis A, et al. FAD synthesis and degradation in the nucleus create a local
                   flavin cofactor pool. J Biol Chem 2013;288:29069-80.
               37.  Leone P, Galluccio M, Barbiroli A, Eberini I, Tolomeo M, et al. Bacterial production, characterization and protein modeling of a novel
                   monofunctional isoform of FAD synthase in humans: an emergency protein? Molecules 2018;23:116-31.
               38.  Torchetti EM, Bonomi F, Galluccio M, Gianazza E, Giancaspero TA, et al. Human FAD synthase (isoform 2): a component of the
                   machinery that delivers FAD to apo-flavoproteins. FEBS J 2011;278:4434-49.
               39.  Taylor RW, Pyle A, Griffin H, Blakely EL, Duff J, et al. Use of whole-exome sequencing to determine the genetic basis of multiple
                   mitochondrial respiratory chain complex deficiencies. JAMA 2014;312:68-77.
               40.  Auranen MA, Paetau A, Piirilä P, Pohju A, Salmi T, et al. Patient with multiple acyl-CoA dehydrogenation deficiency disease and FLAD1
                   mutations benefits from riboflavin therapy. Neuromuscul Disord 2017;27:581-4.
               41.  Yildiz Y, Olsen RKJ, Sivri HS, Akçören Z, Nygaard HH, et al. Post-mortem detection of FLAD1 mutations in 2 Turkish siblings with
                   hypotonia in early infancy. Neuromuscul Disord 2018;28:787-90.
               42.  Ryder B, Tolomeo M, Nochi Z, Colella M, Barile M, et al. A novel truncating FLAD1 variant, causing multiple Acyl-CoA dehydrogenase
                   deficiency (MADD) in an 8-year-old boy. JIMD Rep 2019;45:37-44.
               43.  García-Villoria J, De Azua B, Tort F, Mosegaard S, Ugarteburu O, et al. FLAD1, encoding FAD synthase, is mutated in a patient with
                   myopathy, scoliosis and cataracts. Clin Genet 2018;94:592-3.
               44.  Muru K, Reinson K, Künnapas K, Lilleväli H, Nochi Z, et al. FLAD1-associated multiple acyl-CoA dehydrogenase deficiency identified
                   by newborn screening. Mol Genet Genomic Med 2019;7:e915.
               45.  Yamada K, Ito M, Kobayashi H, Hasegawa Y, Fukuda S, et al. Flavin adenine dinucleotide synthase deficiency due to FLAD1 mutation
                   presenting as multiple acyl-CoA dehydrogenation deficiency-like disease: a case report. Brain Dev 2019;41:638-42.
               46.  Karthikeyan S, Zhou Q, Mseeh F, Grishin NV, Osterman AL, et al. Crystal structure of human riboflavin kinase reveals a beta barrel fold
                   and a novel active site arch. Structure 2003;11:265-73.
               47.  Yazdanpanah B, Wiegmann K, Tchikov V, Krut O, Pongratz C, et al. Riboflavin kinase couples TNF receptor 1 to NADPH oxidase.
                   Nature 2009;460:1159-63.
               48.  Zhang J, Zhang W, Zou D, Chen G, Wan T, et al. Cloning and functional characterization of ACAD-9, a novel member of human acyl-
                   CoA dehydrogenase family. Biochem. Biophys Res Commun 2002;297:1033-42.
               49.  Schiff M, Haberberger B, Xia CW, Mohsen AW, Goetzman ES, et al. Complex I assembly function and fatty acid oxidation enzyme
                   activity of ACAD9 both contribute to disease severity in ACAD9 deficiency. Hum Mol Genet 2015;24:3238-47.
               50.  Nouws J, Te Brinke H, Nijtmans LG, Houten SM. ACAD9, a complex I assembly factor with a moonlighting function in fatty acid
                   oxidation deficiencies. Hum Mol Genet 2014;23:1311-9.
               51.  Repp BM, Mastantuono E, Alston CL, Schiff M, Haack TB, et al. Clinical, biochemical and genetic spectrum of 70 patients with ACAD9
                   deficiency: is riboflavin supplementation effective? Orphanet J Rare Dis 2018;13:120.
               52.  Oey NA, Ruiter JP, Ijlst L, Attie-Bitach T, Vekemans M, et al. Acyl-CoA dehydrogenase 9 (ACAD 9) is the long-chain acyl-CoA
                   dehydrogenase in human embryonic and fetal brain. Biochem Biophys Res Commun 2006;21;346:33-7.
               53.  Lemire BD. Evolution of FOXRED1, an FAD-dependent oxidoreductase necessary for NADH: Ubiquinone oxidoreductase (Complex I)
                   assembly. Biochim. Biophys Acta 2015a;1847:451-7.
               54.  Lemire BD. Glutathione metabolism links FOXRED1 to NADH: ubiquinone oxidoreductase (complex I) deficiency: a hypothesis.
                   Mitochondrion 2015b;24:105-12.
               55.  Barbosa-Gouveia S, González-Vioque E, Borges F, Gutiérrez-Solana L, Wintjes L, et al. Identification and characterization of new
                   variants in FOXRED1 gene expands the clinical spectrum associated with mitochondrial complex I deficiency. J Clin Med 2019;8:1262.
               56.  Calvo SE, Tucker EJ, Compton AG, Kirby DM, Crawford G, et al. High-throughput, pooled sequencing identifies mutations in NUBPL
                   and FOXRED1 in human complex I deficiency. Nat Genet 2010;42:851-8.
   146   147   148   149   150   151   152   153   154   155   156